NCT06224946View on ClinicalTrials.gov

IMPACT OF THE BIOLOGICAL RATIO ON MEDICAL DECISION MAKING IN WOMEN SUSPECTED OF PREECLAMPSIA

CompletedOBSERVATIONAL
Enrollment

314

Participants

Timeline

Start Date

October 1, 2019

Primary Completion Date

January 27, 2021

Study Completion Date

January 27, 2021

Conditions
Pre-Eclampsia
Interventions
DIAGNOSTIC_TEST

soluble fms-like tyrosine kinase (sFlt-1) / placental growth factor (PlGF) ratio

the soluble fms-like tyrosine kinase (sFlt-1) / placental growth factor (PlGF) ratio for pre-eclampsia diagnostic

Trial Locations (1)

42055

Chu Saint-Etienne, Saint-Etienne

All Listed Sponsors
lead

Centre Hospitalier Universitaire de Saint Etienne

OTHER

NCT06224946 - IMPACT OF THE BIOLOGICAL RATIO ON MEDICAL DECISION MAKING IN WOMEN SUSPECTED OF PREECLAMPSIA | Biotech Hunter | Biotech Hunter